Faeth Therapeutics, Inc. (FTH) Debt Components
- 2021-06-30: Long-term Debt, Excluding Current MaturitiesUSD $567.00K; Long-term DebtUSD (m).
- 2021-03-31: Long-term Debt, Excluding Current MaturitiesUSD $567.00K; Long-term DebtUSD (m).
- 2020-12-31: Long-term Debt, Excluding Current MaturitiesUSD $567.00K; Long-term DebtUSD $567.00K.
Faeth Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD |
|---|---|---|
| 2021-06-30 | $567.00K | (m) |
| 2021-03-31 | $567.00K | (m) |
| 2020-12-31 | $567.00K | $567.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |